Loading...

PE anti-human Ki-67 Antibody

Pricing & Availability
Clone
Ki-67 (See other available formats)
Regulatory Status
RUO
Other Names
Antigen Ki-67
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
Ki-67_PE_1_100410
Human T leukemia cell line, Jurkat, fixed and permeabilized with 70% ethanol, then intracellularly stained with Ki-67 PE and counterstained with 7-AAD (Cat No. 420404) for DNA staining.
  • Ki-67_PE_1_100410
    Human T leukemia cell line, Jurkat, fixed and permeabilized with 70% ethanol, then intracellularly stained with Ki-67 PE and counterstained with 7-AAD (Cat No. 420404) for DNA staining.
  • Ki-67_PE_3_100410
    Resting (dashed line) or PHA-activated human peripheral blood lymphocytes (day-3, solid line) fixed and permeabilized with 70% ethanol, then intracellularly stained with Ki-67 PE.
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
350503 25 tests 113€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
350504 100 tests 278€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Antigen Ki-67 is a nuclear protein expressed as two isoforms with molecular weights of 395 and 345 kD. Both isoforms contain one forkhead-associated domain and 16 concatenated "Ki-67 repeats," each containing the epitope recognized by the mAb Ki-67. The antigen Ki-67 interacts with Hklp2, hNIFK, and chromobox protein homolog 1, 3, and 5. Ki-67 is required for cell proliferation and its expression is restricted to the phases G1, S, G2, and M of the cell cycle. This characteristic makes Ki-67 an excellent marker for proliferating cells and is commonly used as one of the prognostic factors in cancer studies. Ki-67 has also been used to study myocyte proliferation after myocardial infarction as well as lymphocyte proliferation during infection, and has been used in neurons of patients with different neuropathologies.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
Cow
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Nuclei of the Hodgkin lymphoma cell line L428
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

ICFC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by our Ki-67 staining protocol below. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of frozen tissue sections1, Western blotting3, and immunofluorescence microscopy4.

Ki-67 Staining Protocol:

1. Prepare 70% ethanol and chill at -20°C.
2. Prepare target cells of interest and wash 2X with PBS by centrifuge at 350xg for 5 minutes.
3. Discard supernatant and loosen the cell pellet by vortexing.
4. Add 3 ml cold 70% ethanol drop by drop to the cell pellet while vortexing.
5. Continue vortexing for 30 seconds and then incubate at -20°C for 1 hour.
6. Wash 3X with BioLegend Cell Staining Buffer and then resuspend the cells at the concentration of 0.5-10 x 106/ml.
7. Mix 100 µl cell suspension with proper fluorochrome-conjugated Ki-67 antibody and incubate at room temperature in the dark for 30 minutes.
8. Wash 2X with BioLegend Cell Staining Buffer and then resuspend in 0.5 ml cell staining buffer for flow cytometric analysis.

Application References
  1. Gerdes J, et al. 1983. Int. J. Cancer 31:13. (IHC)
  2. Gerdes J, et al. 1984. J. Immunol. 133:1710. (ICFC)
  3. Schluter C, et al. 1993 J. Cell Biol. 123:513. (IHC, WB)
  4. Bading H, et al. 1989 Exp. Cell. Res. 185:50. (IF)
  5. Guha P, et al. 2013. PNAS. 110:5052. PubMed
Product Citations
  1. Taylor HE, et al. 2018. AIDS. 32:2847. PubMed
  2. Liu B, et al. 2015. J Virol. 89: 11834 - 11844. PubMed
  3. Chang HP, et al. 2022. Life (Basel). 12: . PubMed
  4. Wang LH, et al. 2022. Diagnostics (Basel). 12: . PubMed
  5. Jung S, et al. 2022. Cell Rep. 40:111138. PubMed
  6. Jo S, et al. 2023. J Bone Miner Res. 38:300. PubMed
  7. Abe I, et al. 2022. Dev Cell. 57:2623. PubMed
  8. Sharma AL, et al. 2022. iScience. 25:105651. PubMed
  9. Perveen R, et al. 2023. Hum Cell. 36:583. PubMed
  10. Perreau M, et al. 2012. J Exp Med. 210:143. PubMed
  11. Hübner M, et al. 2020. Neurooncol Adv. 2:vdaa047. PubMed
  12. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  13. Muellenbeck M, et al. 2013. J Exp Med. 210:389. PubMed
  14. Trotta E, et al. 2018. Nat Med. 24:1005. PubMed
  15. Sugita S, et al. 2016. Stem Cell Reports. 7:619-634. PubMed
  16. Wangler S, et al. 2019. Spine (Phila Pa 1976). 44:1613. PubMed
  17. Gao Y, et al. 2018. Oncol Lett. 15:4781. PubMed
  18. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  19. Wei C, et al. 2016. Cell Death Dis. 7:e2489. PubMed
  20. Jung M, et al. 2016. Sci Signal. 9: ra64. PubMed
  21. Fujii S, et al. 2019. Stem Cells Dev. 28:28. PubMed
  22. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  23. Timilshina M, et al. 2017. PLoS One. 10.1371/journal.pone.0168942. PubMed
  24. Day C, et al. 2017. J Immunol. 10.4049/jimmunol.1700558. PubMed
  25. Pembroke T, et al. 2014. Gut. 63:515. PubMed
  26. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  27. Makabe K, et al. 2019. Invest Ophthalmol Vis Sci. 60:1298. PubMed
  28. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  29. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  30. Su Y, et al. 2020. Cell. 1479:183. PubMed
  31. Seo IH, et al. 2021. Cell Reports. 36(4):109438. PubMed
  32. Li M, et al. 2020. Virol Sin. 35:588. PubMed
RRID
AB_10660752 (BioLegend Cat. No. 350503)
AB_10660752 (BioLegend Cat. No. 350504)

Antigen Details

Structure
Two isoforms with molecular weights of 395 and 345 kD, one forkhead-associated domain, 16 concatenated Ki-67 repeats, located in nucleus
Distribution

Expressed in the phases G1, S, G2, and M of the cell cycle

Function
Required for cell proliferation
Interaction
Chromobox protein homolog 1, 3 and 5, Hklp2, and hNIFK
Biology Area
Cell Biology, Cell Cycle/DNA Replication, DNA Repair/Replication
Molecular Family
Nuclear Markers
Antigen References

1. Byeon IJ, et al. 2005. Nat. Struct. Mol. Biol. 12:987.
2. Yerushalmi R, et al. 2010. Lancet. Oncol. 11:174.
3. Beltrami AP, et al. 2001. N. Engl. J. Med. 344:1750.
4. Sachsenberg N, et al. 1998. J. Exp. Med. 187:1295.
5. Nagy Z, et al. 1997. Acta. Neuropathol. 93:294.

Gene ID
4288 View all products for this Gene ID
UniProt
View information about Ki-67 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 4    Revision Date: 07.16.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account